Novel Molecular Targets for Hepatocellular Carcinoma

Area of Science:

• Oncology
• Immunology
• Proteomics

Background:

• Hepatocellular carcinoma (HCC) is a leading global cause of cancer mortality.
• Limited treatment options exist, primarily effective for early-stage disease.
• There is a critical need for targeted therapies and biomarkers for advanced HCC.

Purpose of the Study:

• To identify novel HCC-specific tumor-associated antigens (TAAs) for targeted immunotherapy.
• To explore potential epitopes for T-cell based therapeutic strategies.
• To assess T-cell cross-reactivity with identified HCC-specific epitopes.

Main Methods:

• Candidate proteins were selected from The Human Protein Atlas database.
• Bioinformatic analysis predicted potential epitopes and assessed homology with viral peptides.
• Multiparametric validation included peripheral blood mononuclear cell (PBMC) recognition assays.

Main Results:

• Novel HCC-specific TAAs were identified.
• Predicted epitopes demonstrated T-cell cross-reactivity in HCC patients.
• Cross-reactivity was observed with pre-existing virus-specific T cells.

Conclusions:

• The study identified promising HCC-specific TAAs for novel immunotherapeutic strategies.
• These TAAs can potentially expand virus-specific CD8+ T cells for enhanced anti-HCC efficacy.
• This research paves the way for new targeted immunotherapies against hepatocellular carcinoma.